179 related articles for article (PubMed ID: 1374166)
21. Crystals of a ternary complex of human immunodeficiency virus type 1 reverse transcriptase with a monoclonal antibody Fab fragment and double-stranded DNA diffract x-rays to 3.5-A resolution.
Jacobo-Molina A; Clark AD; Williams RL; Nanni RG; Clark P; Ferris AL; Hughes SH; Arnold E
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10895-9. PubMed ID: 1720554
[TBL] [Abstract][Full Text] [Related]
22. Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.
Patel PH; Jacobo-Molina A; Ding J; Tantillo C; Clark AD; Raag R; Nanni RG; Hughes SH; Arnold E
Biochemistry; 1995 Apr; 34(16):5351-63. PubMed ID: 7537090
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain.
Wu J; Amandoron E; Li X; Wainberg MA; Parniak MA
J Biol Chem; 1993 May; 268(14):9980-5. PubMed ID: 7683687
[TBL] [Abstract][Full Text] [Related]
24. Active site labeling of HIV-1 reverse transcriptase.
Sheng N; Dennis D
Biochemistry; 1993 May; 32(18):4938-42. PubMed ID: 7683913
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase.
Georgiadis MM; Jessen SM; Ogata CM; Telesnitsky A; Goff SP; Hendrickson WA
Structure; 1995 Sep; 3(9):879-92. PubMed ID: 8535782
[TBL] [Abstract][Full Text] [Related]
26. Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP.
Pelletier H; Sawaya MR; Kumar A; Wilson SH; Kraut J
Science; 1994 Jun; 264(5167):1891-903. PubMed ID: 7516580
[TBL] [Abstract][Full Text] [Related]
27. 2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains).
Unge T; Knight S; Bhikhabhai R; Lövgren S; Dauter Z; Wilson K; Strandberg B
Structure; 1994 Oct; 2(10):953-61. PubMed ID: 7532533
[TBL] [Abstract][Full Text] [Related]
28. Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors, and an antibody Fab fragment.
Clark AD; Jacobo-Molina A; Clark P; Hughes SH; Arnold E
Methods Enzymol; 1995; 262():171-85. PubMed ID: 8594346
[No Abstract] [Full Text] [Related]
29. Hydroxyl radical footprint analysis of human immunodeficiency virus reverse transcriptase-template.primer complexes.
Metzger W; Hermann T; Schatz O; Le Grice SF; Heumann H
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5909-13. PubMed ID: 7687057
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not.
Boyer PL; Tantillo C; Jacobo-Molina A; Nanni RG; Ding J; Arnold E; Hughes SH
Proc Natl Acad Sci U S A; 1994 May; 91(11):4882-6. PubMed ID: 7515182
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors.
Rittinger K; Divita G; Goody RS
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8046-9. PubMed ID: 7544013
[TBL] [Abstract][Full Text] [Related]
32. Structure of HIV-1 reverse transcriptase bound to a novel 38-mer hairpin template-primer DNA aptamer.
Miller MT; Tuske S; Das K; DeStefano JJ; Arnold E
Protein Sci; 2016 Jan; 25(1):46-55. PubMed ID: 26296781
[TBL] [Abstract][Full Text] [Related]
33. The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor.
Jaeger J; Restle T; Steitz TA
EMBO J; 1998 Aug; 17(15):4535-42. PubMed ID: 9687519
[TBL] [Abstract][Full Text] [Related]
34. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.
Rodgers DW; Gamblin SJ; Harris BA; Ray S; Culp JS; Hellmig B; Woolf DJ; Debouck C; Harrison SC
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1222-6. PubMed ID: 7532306
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of HIV-1 reverse transcriptase. Termination of processive synthesis on a natural DNA template is influenced by the sequence of the template-primer stem.
Abbotts J; Bebenek K; Kunkel TA; Wilson SH
J Biol Chem; 1993 May; 268(14):10312-23. PubMed ID: 7683674
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 reverse transcriptase: structure predictions for the polymerase domain.
Barber AM; Hizi A; Maizel JV; Hughes SH
AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1061-72. PubMed ID: 1702298
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.
Gopalakrishnan V; Peliska JA; Benkovic SJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10763-7. PubMed ID: 1279694
[TBL] [Abstract][Full Text] [Related]
38. Proteolytic release and crystallization of the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase.
Hostomska Z; Matthews DA; Davies JF; Nodes BR; Hostomsky Z
J Biol Chem; 1991 Aug; 266(22):14697-702. PubMed ID: 1713588
[TBL] [Abstract][Full Text] [Related]
39. HIV reverse transcriptase structure-function relationships.
Jacobo-Molina A; Arnold E
Biochemistry; 1991 Jul; 30(26):6351-6. PubMed ID: 1711368
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.
Kohlstaedt LA; Wang J; Friedman JM; Rice PA; Steitz TA
Science; 1992 Jun; 256(5065):1783-90. PubMed ID: 1377403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
